Diagnostic performance of noninvasive imaging modalities for localization of insulinoma: A meta-analysis
Authors:
- 1 December 2021
- journal article
- research article
- Published by Elsevier in European Journal of Radiology
- Vol. 145, 110016
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (6192780137)
This publication has 35 references indexed in Scilit:
- Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-exendin-4 for the detection of insulinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Systematic Reviews of Studies Quantifying the Accuracy of Diagnostic Tests and MarkersClinical Chemistry, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Surgical management of patients with insulinomas: Result of 292 cases in a single institutionJournal of Surgical Oncology, 2010
- GLP-1 Receptor Expression in Human Tumors and Human Normal Tissues: Potential for In Vivo TargetingJournal of Nuclear Medicine, 2007
- Well-Differentiated Pancreatic Tumor/Carcinoma: InsulinomaNeuroendocrinology, 2006
- InsulinomaBest Practice & Research Clinical Gastroenterology, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003
- Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activityDiabetologia, 1998
- Functioning Insulinoma—Incidence, Recurrence, and Long-Term Survival of Patients: A 60-Year StudyMayo Clinic Proceedings, 1991